Reference105 articles.
1. I. Olivieri, N.F., and Brittenham, G.M., 1997, Iron chelating therapy and the treatment of thalassemiaBlood89:739.
2. Richardson, D.R., and Ponka, P., 1998, The development of iron chelators to treat iron overload disease and their use as experimental tools to study intracellular iron metabolismAm. J. Hematol.58:299.
3. Donfrancesco, A., Deb, G., De Sio, L., Cozza, R., and Castellano, A., 1996, Role of desferrioxamine in tumor therapyActa Haematol.95:66.
4. Richardson, D.R., 1997, Iron chelators as effective anti-proliferative agentsCan. J. Physiol. Pharmacol.75:1164.
5. Hentze, M.W., and Kuhn, L.C., 1996, Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stressProc. Natl. Acad. Sci. USA93:8175.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献